053950 Stock Chart & Stats
₩1435.00
-₩96.00(-6.27%)
―
--
Day’s Range― - ―
52-Week Range₩1,415.00 - ₩5,580.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)297.05K
Market Cap
₩30.04B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta<0.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding19,619,650
10 Day Avg. Volume45,036
30 Day Avg. Volume297,047
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2,268,809.77
Revenue Forecast (FY)₩10.00T>
053950 FAQ
What was Kyungnam Pharm Co., Ltd.’s price range in the past 12 months?
Kyungnam Pharm Co., Ltd. lowest stock price was ₩1415.00 and its highest was ₩5580.00 in the past 12 months.
What is Kyungnam Pharm Co., Ltd.’s market cap?
Kyungnam Pharm Co., Ltd.’s market cap is ₩30.04B.
When is Kyungnam Pharm Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kyungnam Pharm Co., Ltd.’s earnings last quarter?
Kyungnam Pharm Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩45.083 earnings per share for the quarter, missing the consensus estimate of N/A by -₩45.083.
Is Kyungnam Pharm Co., Ltd. overvalued?
According to Wall Street analysts Kyungnam Pharm Co., Ltd.’s price is currently Undervalued.
Does Kyungnam Pharm Co., Ltd. pay dividends?
Kyungnam Pharm Co., Ltd. does not currently pay dividends.
What is Kyungnam Pharm Co., Ltd.’s EPS estimate?
Kyungnam Pharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kyungnam Pharm Co., Ltd. have?
Kyungnam Pharm Co., Ltd. has 19,619,650 shares outstanding.
What happened to Kyungnam Pharm Co., Ltd.’s price movement after its last earnings report?
Kyungnam Pharm Co., Ltd. reported an EPS of -₩45.083 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.39%.
Which hedge fund is a major shareholder of Kyungnam Pharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:053950
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dongsung Pharmaceutical Co., Ltd.
―
Seoul Pharma Co., Ltd.
―
Daesung Microbiological Laboratories Co., Ltd.
―
POONGJEON PHARMACY CO., LTD.
―
SG Healthcare Co., Ltd.
―